Twist Bioscience (TWST) Depreciation & Amortization (CF) (2017 - 2026)

Twist Bioscience (TWST) has reported Depreciation & Amortization (CF) for 10 consecutive years, with $6.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 11.76% year-over-year to $6.8 million in Q2 2026; TTM through Jun 2026 was $25.4 million, a 0.44% change from a year earlier, with the FY2025 full-year figure at $24.9 million, down 20.93% from the prior year.
• Depreciation & Amortization (CF) was $6.8 million for Q2 2026 at Twist Bioscience, up from $6.4 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $8.5 million in Q3 2023 and troughed at $4.0 million in Q1 2022.
• A 5-year average of $6.6 million and a median of $6.4 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) jumped 99.6% in 2022 and declined 26.94% in 2025, its largest moves.
• Over 5 years, Depreciation & Amortization (CF) stood at $5.3 million in 2022, then surged by 54.4% to $8.2 million in 2023, then slipped by 21.92% to $6.4 million in 2024, then decreased by 2.92% to $6.2 million in 2025, then grew by 9.43% to $6.8 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $6.8 million (Q2 2026), $6.4 million (Q1 2026), and $6.2 million (Q4 2025), per Business Quant data.